- Home
- / Senti Biosciences
Senti Biosciences
Stock Price
$2.2
2024-10-29
Market Capitalization
$10.2 M
2024-10-29
Revenue
$22 K
FY, 2025
Senti Biosciences Summary
Company Summary
- Overview
- Senti Biosciences (formerly known as Dynamics Special Purpose) leverages expertise in cell engineering and biological programming to build the future of gene and cell based therapies. The company is developing novel therapeutics to solve challenging and complex diseases.
- Type
- Public
- Status
- Active
- Founded
- 2016
- HQ
- South San Francisco, CA, US | view all locations
- Website
- https://www.sentibio.com/
- Cybersecurity rating
Table of Contents
Key People
Wilson Wong, Scientific Co-Founder
Deborah Knobelman, Chief Financial Officer & Head of Corporate Development
Ed Mathers, Director
LocationsView all
1 location detected
South San Francisco, CA HQ
United States
2 Corporate Drive First Floor
Senti Biosciences Financials
Summary Financials
- Revenue (Q1, 2026)
- $16.0K
- Net income (Q1, 2026)
- ($4.2M)
- Cash (Q1, 2026)
- $8.9M
- EBIT (Q1, 2026)
- ($4.6M)
- Enterprise value
- $20.4M